p70 S6 Kinase Recombinant Rabbit Monoclonal Antibody: A Powerful Tool for Analyzing the mTOR Signaling Hub

ANT BIO PTE. LTD. is a global leading supplier of high-quality life science reagents, offering a comprehensive product portfolio that includes antibodies, recombinant proteins, specialized assay kits, and general life science reagents. The company operates three strategically positioned sub-brands to cater to diverse research needs: Absin specializes in general life science reagents and experimental kits, Starter is dedicated to advanced antibody products, and UA focuses on the R&D and production of high-purity recombinant proteins. This article delves into the critical role of p70 S6 kinase as a central node in the mTOR signaling pathway, explores the design principles and application value of its recombinant rabbit monoclonal antibody, and highlights how ANT BIO PTE. LTD.’s product empowers research on signaling networks, tumor biology, and drug development.

1. Concept: p70 S6 Kinase and Its Central Role in the mTOR Signaling Hub

p70 S6 kinase is a serine/threonine kinase belonging to the AGC kinase family, serving as one of the most pivotal effector molecules downstream of the mammalian target of rapamycin complex 1 (mTORC1). It exists in two isoforms—S6K1 and S6K2—encoded by distinct genes yet sharing high sequence homology. As a core component of the mTOR signaling pathway, p70 S6 kinase plays a fundamental role in regulating key cellular processes, including protein synthesis, cell growth, metabolic reprogramming, and cell cycle progression, primarily through phosphorylating ribosomal protein S6 and a range of downstream substrates.

The activation of p70 S6 kinase is tightly controlled by multi-layered signaling inputs: it relies on phosphorylation modifications mediated by mTORC1 and synergistic signals from the phosphoinositide 3-kinase (PI3K) pathway. Under physiological conditions, its activity is stringently regulated to maintain cellular homeostasis; however, in pathological states—particularly in cancer—aberrant activation of the p70 S6 kinase signaling axis is closely linked to tumor initiation, progression, and metastasis. Clinical studies have documented S6K1 gene amplification and overexpression in breast, ovarian, and gastric cancers, with such abnormalities positively correlated with poor patient prognosis.

Given its status as a central node in the mTOR signaling hub, p70 S6 kinase has become a key target for elucidating tumor signaling networks and developing targeted therapies. Accurate detection of its expression levels, activation states (via phosphorylation), and subcellular localization is essential for unraveling its functional mechanisms, making the development of high-quality specific antibodies a critical research need.

2. Research Frontiers: Design Principles of p70 S6 Kinase Recombinant Rabbit Monoclonal Antibodies

The development of recombinant rabbit monoclonal antibodies targeting p70 S6 kinase requires precise consideration of the kinase’s molecular characteristics, activation mechanisms, and experimental application scenarios. As research in signaling biology and tumor pharmacology advances, the demand for antibodies with high specificity, affinity, and versatility across multiple platforms has grown exponentially. The design of such antibodies must address key molecular features of p70 S6 kinase to ensure reliable and accurate research outcomes.

2.1 Key Molecular Features Guiding Antibody Design

1. Domain and isoform specificity: p70 S6 kinase comprises three structural domains—an N-terminal domain, a kinase domain, and a C-terminal domain—with activation dependent on phosphorylation at critical sites (e.g., Thr229 in the activation loop and Thr389 in the hydrophobic motif). Antibody design must distinguish between two core applications: total protein detection (targeting conserved sequences across isoforms) and phosphorylation-specific detection (specifically recognizing activated forms via key phosphorylation sites such as Thr389). Additionally, since S6K1 and S6K2 exhibit sequence differences, isoform-specific antibodies require targeting unique antigenic regions of each isoform to avoid cross-reactivity.
2. Epitope stability and application adaptability: For immunohistochemical (IHC) applications in formalin-fixed paraffin-embedded (FFPE) tumor tissues, antibodies must recognize epitopes that remain stable under cross-linking conditions induced by fixation. When using recombinant proteins or synthetic peptides as immunogens, it is critical to cover diverse domains and modification states to enrich antibody clones with varying specificities (e.g., conformational epitopes vs. linear epitopes).
3. Advantages of the rabbit immune system: The rabbit immune system possesses a unique antibody maturation mechanism, enabling the production of high-affinity antibodies that recognize conformational epitopes and post-translational modification (PTM)-dependent epitopes—key advantages for detecting the dynamic activation states of p70 S6 kinase.

The diagram illustrates the domain structure of p70 S6 kinase (N-terminal, kinase, and C-terminal domains) and its position within the mTOR signaling hub. It highlights key phosphorylation sites (Thr229, Thr389) critical for activation, as well as upstream regulators (mTORC1, PI3K) and downstream substrates (ribosomal protein S6), emphasizing the kinase’s role as a central signaling node.

2.2 Core Performance Requirements for Antibodies

To effectively analyze the mTOR signaling hub, p70 S6 kinase recombinant rabbit monoclonal antibodies must meet stringent performance criteria:

• High specificity: Minimal cross-reactivity with other AGC family kinases (e.g., Akt, PKC, RSK) and S6K2 isoform to ensure accurate detection of the target isoform (e.g., S6K1) in complex cellular and tissue samples.
• High affinity and sensitivity: Capable of detecting low-abundance p70 S6 kinase and its phosphorylated forms, enabling reliable signal detection in Western Blot (WB), immunoprecipitation (IP), and immunofluorescence (IF) assays.
• Versatility across platforms: Validated for use in multiple experimental techniques (WB, IP, IF, IHC, flow cytometry) to accommodate diverse research needs, from protein expression profiling to subcellular localization and tissue-level analysis.
• Batch-to-batch consistency: Stable performance across production batches to ensure reproducibility in long-term research projects, multi-center studies, and drug development workflows.

3. Research Significance of p70 S6 Kinase Antibodies in Signaling and Tumor Research

The p70 S6 kinase recombinant rabbit monoclonal antibody serves as an indispensable tool for deciphering the mTOR signaling hub and its role in physiology and disease, with profound research significance across multiple fields:

1. Unraveling signaling network regulation: The antibody enables the analysis of p70 S6 kinase activation dynamics, upstream regulatory inputs, and downstream effector pathways, facilitating the mapping of complex signaling crosstalk between mTOR, PI3K, and other oncogenic pathways.
2. Tumor biology and biomarker research: By detecting p70 S6 kinase expression and phosphorylation levels in tumor tissues and cell lines, the antibody supports the identification of prognostic biomarkers and the stratification of patient populations for targeted therapy.
3. Drug development and target validation: As a key tool for assessing target engagement, the antibody enables the evaluation of mTOR/p70 S6 kinase pathway inhibitors, accelerating the development of anti-tumor drugs and the optimization of combination therapy strategies.
4. Basic cellular biology research: The antibody facilitates studies on protein synthesis regulation, cell growth control, and metabolic reprogramming, advancing our understanding of fundamental cellular processes and their dysregulation in disease.

4. ANT BIO PTE. LTD. p70 S6 Kinase Recombinant Rabbit Monoclonal Antibody: Applications and Advantages

ANT BIO PTE. LTD. has independently developed a high-performance p70 S6 Kinase Recombinant Rabbit mAb (Catalog No.: S0B0875) through its Starter sub-brand. Specifically designed to target the conserved kinase domain of p70 S6 kinase (S6K1, encoded by the RPS6KB1 gene), this antibody exhibits high specificity, affinity, and versatility, making it a core tool for mTOR signaling pathway research, tumor biology, and drug development.

4.1 Core Advantages of the Product

1. Exceptional target specificity: Developed via precise antigen design and epitope screening, the antibody specifically recognizes the conserved kinase domain of p70 S6K (S6K1) with minimal cross-reactivity to S6K2 and other AGC family kinases (e.g., Akt, PKC, RSK). This high specificity ensures accurate detection and quantification of the target protein in complex biological samples, avoiding false-positive results.
2. Superior affinity and sensitivity: Leveraging the recombinant rabbit monoclonal antibody platform, the product exhibits inherently high affinity for p70 S6K, enabling high-sensitivity detection with low background noise across multiple applications (WB, IP, IF, IHC, flow cytometry). It can reliably detect low-abundance p70 S6K and its phosphorylated forms, even in limited sample quantities.
3. Multi-platform versatility: Rigorously validated for use in a wide range of experimental techniques, the antibody adapts to diverse research scenarios:
• WB: Detection of p70 S6K total protein expression and activation (via phosphorylation-specific assays when paired with phospho-antibodies);
• IP: Immunoprecipitation of p70 S6K and its interacting protein complexes for downstream mass spectrometry (MS) analysis;
• IF: Visualization of p70 S6K subcellular localization and spatial distribution in cells and tissue sections;
• IHC: Detection of p70 S6K expression in FFPE tumor tissues for clinical sample analysis;
• Flow cytometry: Quantitative analysis of p70 S6K expression in heterogeneous cell populations.
4. Excellent stability and batch-to-batch consistency: Produced using a standardized recombinant expression system, the antibody undergoes strict quality control, ensuring consistent performance across batches. Its stable physicochemical properties make it ideal for long-term research projects, multi-center collaborations, and methodological development.

4.2 Key Application Scenarios

The p70 S6 Kinase Recombinant Rabbit mAb offers broad utility in signaling pathway research, tumor biology, and drug development, with key application scenarios including:

4.2.1 Tumor Organoid Model Research

Tumor organoids—3D culture models that retain the tissue architecture and heterogeneity of primary tumors—are valuable platforms for mechanism research and drug screening. The antibody enables:

• Analysis of mTOR signaling pathway activation states at the organoid level via immunofluorescence staining, revealing the spatial distribution of p70 S6K and its phosphorylated forms (e.g., higher S6 phosphorylation in the proliferative peripheral zone vs. the nutrient-limited central zone);
• Evaluation of mTOR inhibitors and S6K-specific inhibitors in drug intervention experiments, establishing correlations between target engagement (measured via p70 S6K phosphorylation) and organoid growth inhibition;
• Verification of S6K1/S6K2 knockout efficiency and signal compensation mechanisms in gene-edited organoid models;
• Elucidation of crosstalk between tumor cell-intrinsic signals and the immune microenvironment when combined with immune cell marker antibodies in co-culture systems.

4.2.2 Signaling Network Regulatory Mechanism Research

The antibody is a powerful tool for dissecting the mTOR signaling hub and its regulatory networks:

• Identification of p70 S6K-interacting protein complexes via IP-MS analysis, uncovering novel downstream substrates and regulatory partners;
• Visualization of p70 S6K spatiotemporal dynamics (e.g., translocation to the cell membrane and perinuclear regions upon insulin or growth factor stimulation) using high-resolution imaging combined with IF;
• Investigation of drug resistance mechanisms by detecting reactivation of the S6K signaling pathway in mTOR inhibitor-resistant cell lines, revealing bypass signaling activation and compensatory mechanisms.

4.2.3 Anti-Tumor Drug Development and Evaluation

As a critical tool for target engagement assessment, the antibody supports multiple stages of drug development:

• Construction of phosphorylation-specific ELISA systems for quantitative measurement of kinase activity changes following inhibitor treatment;
• Establishment of correlations between target engagement (p70 S6K phosphorylation inhibition) and cell proliferation suppression in in vitro efficacy evaluations;
• High-throughput imaging analysis of compound libraries in organoid drug screening to assess inhibitory effects on the S6K signaling pathway;
• Evaluation of inhibitor efficiency and duration of action in vivo via tumor tissue staining in preclinical animal models;
• Screening of synergistic combination therapy strategies by detecting additive inhibitory effects of drug combinations on p70 S6K phosphorylation and downstream signaling.

4.3 Professional Technical Support

ANT BIO PTE. LTD. provides comprehensive technical documentation and expert support for the p70 S6 Kinase Recombinant Rabbit mAb, including:

• Detailed validation data: Specificity validation (cross-reactivity analysis with S6K2 and AGC family kinases), species cross-reactivity data (human, mouse, rat, etc.), and multi-platform performance reports;
• Optimized application protocols: Recommended experimental conditions for WB, IP, IF, IHC, and flow cytometry, including sample preparation, antibody dilution ratios, and detection workflows;
• Expert consultation: One-on-one support from a professional technical team for experimental design, signaling pathway analysis, tumor metabolism research, and drug mechanism studies.

5. Related Product List

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.